Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TRK-950 |
Synonyms | |
Therapy Description |
TRK-950 is a monoclonal antibody that targets Caprin-1, potentially leading to antitumor activity (European Journal of Cancer 174 (2022): S32-S33). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TRK-950 | TRK 950|TRK950 | TRK-950 is a monoclonal antibody that targets Caprin-1, potentially leading to antitumor activity (European Journal of Cancer 174 (2022): S32-S33). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02990481 | Phase I | TRK-950 | A Study of TRK-950 in Patients With Advanced Solid Tumors | Completed | USA | FRA | 0 |